Skip to main content

Table 2 Patients baseline characteristics

From: Duodenal microbiota and weight-loss following sleeve gastrectomy and Roux-en-Y gastric bypass – a pilot study

Characteristic

All (n = 32)

Group 0 (n = 17)

Group 1 (n = 15)

p-value

Male, n (%)

12 (37.5%)

6 (35.3%)

6 (40.0%)

1.000

Age (years), mean (SD)

42.38 (10.61)

45.82 (9.84)

38.47 (10.37)

0.048

Max. Weight (kg), mean (SD)

144.02 (27.21)

147.12 (24.72)

140.50 (30.27)

0.501

Max. BMI (kg/m2), mean (SD)

48.97 (6.50)

50.00 (6.00)

47.80 (7.05)

0.347

Weight loss before the surgery (kg), median (Q1-Q3)

2.50 (0.00—5.50)

3.00 (0.00—4.50)

0.00 (0.00—6.00)

0.911

BMI before the surgery (kg/m2), mean (SD)

47.75 (6.60)

48.93 (6.00)

46.42 (7.20)

0.292

Comorbidities

 GERD, n (%)

4 (12.5%)

2 (11.8%)

2 (13.3%)

1.000

 Diabetes, n (%)

10 (31.3%)

6 (35.3%)

4 (26.7%)

0.712

 Insulin resistance, n (%)

2 (6.3%)

2 (11.8%)

0 (0.0%)

0.486

 Dyslipidaemia, n (%)

23 (71.9%)

11 (64.7%)

12 (80.0%)

0.444

 Liver steatosis, n (%)

26 (81.3%)

13 (76.5%)

13 (86.7%)

0.659

 Hypertension, n (%)

23 (71.9%)

13 (76.5%)

10 (66.7%)

0.699

 Another cardiologic diseases, n (%)

3 (9.4%)

2 (11.8%)

1 (6.7%)

1.000

 Respiratory disorders, n (%)

6 (18.8%)

2 (11.8%)

4 (26.7%)

0.383

 Joints disorders, n (%)

16 (50.0%)

10 (58.8%)

6 (40.0%)

0.479

 Varices, n (%)

6 (18.8%)

3 (17.6%)

3 (20.0%)

1.000

 Smoking, n (%)

3 (9.4%)

2 (11.8%)

1 (6.7)

1.000

 ASA scale, median (Q1-Q3)

2 (2–3)

2 (2–3)

2 (2–3)

0.710

 ASA 1, n (%)

3 (9.4%)

1 (5.9%)

2 (13.3%)

0.770

 ASA 2, n (%)

20 (62.5%)

11 (64.7%)

9 (60.0%)

0.770

 ASA 3, n (%)

9 (28.1%)

5 (29.4%)

4 (26.7%)

0.770